FDA Inspection 1257894 — Hefei Lifeon Pharmaceutical Co., Ltd. (API Branch)
The FDA completed an inspection of Hefei Lifeon Pharmaceutical Co., Ltd. (API Branch) on Nov 22, 2024 in Hefei. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hefei (China)